Capricor Therapeutics, Inc.CAPRNASDAQ
Loading
Year-over-year revenue growth rate
| Period | Value |
|---|---|
| Q4 2025 | 0.00% |
| Q3 2025 | 0.00% |
| Q2 2025 | 0.00% |
| Q1 2025 | -100.00% |
| Q4 2024 | 392.14% |
| Q3 2024 | -43.05% |
| Q2 2024 | -19.06% |
| Q1 2024 | -59.41% |
| Q4 2023 | 95.42% |
| Q3 2023 | 57.90% |
| Q2 2023 | 31.16% |
| Q1 2023 | 211.15% |
| Q4 2022 | -39.69% |
| Q3 2022 | 0.00% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |
| Q4 2021 | 0.00% |
| Q3 2021 | -100.00% |
| Q2 2021 | 400.00% |
| Q1 2021 | -29.42% |
| Q4 2020 | 242.94% |
| Q3 2020 | -66.18% |
| Q2 2020 | -73.15% |
| Q1 2020 | -16.39% |
| Q4 2019 | 56.33% |
| Q3 2019 | -65.38% |
| Q2 2019 | 78.02% |
| Q1 2019 | -64.43% |
| Q4 2018 | 195.59% |
| Q3 2018 | -45.73% |
| Q2 2018 | 0.97% |
| Q1 2018 | 0.00% |
| Q4 2017 | -100.00% |
| Q3 2017 | -68.56% |
| Q2 2017 | 13.13% |
| Q1 2017 | 28.85% |
| Q4 2016 | 0.00% |
| Q3 2016 | -25.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |